Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1994
The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acidJ H Sips, O van Tellingen, W J Nooijen, et al.
Gut|December 1, 1995
Absence of ras gene mutations in early gastric carcinomasM E Craanen, P Blok, B Top, et al.
Breast Cancer Research and Treatment|November 26, 1999
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cellsA C Lambrechts, A J Bosma, S G Klaver, et al.
The Journal of Clinical Investigation|February 1, 1994
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomasJ A Kern, R J Slebos, B Top, et al.
Cancer Investigation|January 1, 1995
Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancerS Rodenhuis, E van der Wall, W W ten Bokkel Huinink, et al.
Genes, Chromosomes & Cancer|February 1, 1995
N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implicationsR A Olie, L H Looijenga, L Boerrigter, et al.
Therapeutic Drug Monitoring|October 1, 1995
Monitoring carboplatin concentrations in saliva: a replacement for plasma ultrafiltrate measurements?L J van Warmerdam, O van Tellingen, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancerW W ten Bokkel Huinink, L J van Warmerdam, T J Helmerhorst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative GroupJ B Vermorken, J Verweij, P H de Mulder, et al.
Seminars in Oncology|February 1, 1997
Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding studyW ten Bokkel Huinink, C Veenhof, M Huizing, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|January 1, 1994
The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acidJ H Sips, O van Tellingen, W J Nooijen, et al.
Gut|December 1, 1995
Absence of ras gene mutations in early gastric carcinomasM E Craanen, P Blok, B Top, et al.
Breast Cancer Research and Treatment|November 26, 1999
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cellsA C Lambrechts, A J Bosma, S G Klaver, et al.
The Journal of Clinical Investigation|February 1, 1994
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomasJ A Kern, R J Slebos, B Top, et al.
Cancer Investigation|January 1, 1995
Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancerS Rodenhuis, E van der Wall, W W ten Bokkel Huinink, et al.
Genes, Chromosomes & Cancer|February 1, 1995
N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implicationsR A Olie, L H Looijenga, L Boerrigter, et al.
Therapeutic Drug Monitoring|October 1, 1995
Monitoring carboplatin concentrations in saliva: a replacement for plasma ultrafiltrate measurements?L J van Warmerdam, O van Tellingen, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancerW W ten Bokkel Huinink, L J van Warmerdam, T J Helmerhorst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative GroupJ B Vermorken, J Verweij, P H de Mulder, et al.
Seminars in Oncology|February 1, 1997
Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding studyW ten Bokkel Huinink, C Veenhof, M Huizing, et al.
Pageof 15